Skip to main content

Vertex Pharmaceuticals Product revenues, net revenue

  • VRTX · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$538.60−0.74%Close 13 Nov 2026

Product revenues, net revenue at Vertex Pharmaceuticals came to $3.4B for the quarter to 30 Sep 2026, up 11.8% from a year earlier.

As Vertex Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$2.3BDec 2022$2.7BMar 2024$2.6BJun 2024$2.8BSep 2024$2.9BDec 2024$2.8BMar 2025$2.9BJun 2025$3.1BSep 2025$3.2BDec 2025$3.0BMar 2026$3.3BJun 2026$3.4BSep 2026
Vertex Pharmaceuticals Product revenues, net revenue, every reported period
Period endingProduct revenues, net revenueChange on a yearFiled
30 Sep 2026$3.4Bup 11.8%3 Nov 2026
30 Jun 2026$3.3Bup 13.2%4 Aug 2026
31 Mar 2026$3.0Bup 8.2%5 May 2026
31 Dec 2025$3.2Bup 9.5%13 Feb 2026
30 Sep 2025$3.1Bup 11.0%4 Nov 2025
30 Jun 2025$2.9Bup 11.3%5 Aug 2025
31 Mar 2025$2.8Bup 2.6%6 May 2025
31 Dec 2024$2.9B—13 Feb 2025
30 Sep 2024$2.8B—5 Nov 2024
30 Jun 2024$2.6B—2 Aug 2024
31 Mar 2024$2.7B—7 May 2024
31 Dec 2022$2.3Bup 11.1%10 Feb 2023
30 Sep 2022$2.3Bup 17.7%28 Oct 2022
30 Jun 2022$2.2Bup 22.5%5 Aug 2022
31 Mar 2022$2.1Bup 21.7%6 May 2022
31 Dec 2021$2.1Bup 27.4%9 Feb 2022
30 Sep 2021$2.0Bup 29.2%3 Nov 2021
30 Jun 2021$1.8Bup 17.6%30 Jul 2021
31 Mar 2021$1.7Bup 13.7%30 Apr 2021
31 Dec 2020$1.6Bup 15.1%11 Feb 2021
30 Sep 2020$1.5Bup 61.7%30 Oct 2020
30 Jun 2020$1.5Bup 62.1%31 Jul 2020
31 Mar 2020$1.5Bup 76.7%1 May 2020
31 Dec 2019$1.4Bup 62.8%13 Feb 2020
30 Sep 2019$949.8Mup 21.4%31 Oct 2019
30 Jun 2019$940.4Mup 25.4%1 Aug 2019
31 Mar 2019$857.3Mup 34.4%1 May 2019
31 Dec 2018$868.2Mup 39.8%13 Feb 2019
30 Sep 2018$782.5Mup 42.4%25 Oct 2018
30 Jun 2018$749.9Mup 45.9%26 Jul 2018
31 Mar 2018$637.7Mup 32.7%27 Apr 2018
31 Dec 2017$621.2M—15 Feb 2018
30 Sep 2017$549.6M—30 Oct 2017
30 Jun 2017$514.0M—28 Jul 2017
31 Mar 2017$480.6M—28 Apr 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Vertex Pharmaceuticals: TRIKAFTA/KAFTRIO revenue · ALYFTREK revenue · CASGEVY revenue · JOURNAVX revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of VRTX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.